Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperlipidemias, Hypercholesterolemia, Mixed Dyslipidemia”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Large-scale testing (Phase 3)Ended earlyNCT01294683
What this trial is testing

Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants With Primary Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-118)

Who this might be right for
Primary HypercholesterolemiaDyslipidemia
Merck Sharp & Dohme LLC 977
Large-scale testing (Phase 3)Study completedNCT07295418
What this trial is testing

SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hyperlipidemias
Shenzhen Salubris Pharmaceuticals Co., Ltd. 618
Large-scale testing (Phase 3)Study completedNCT00138762
What this trial is testing

Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

Who this might be right for
Hyperlipidemia
Pfizer 3,800
Not applicableStudy completedNCT01245738
What this trial is testing

Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)

Who this might be right for
DyslipidemiasHypercholesterolemiaHypertriglyceridemia+2 more
Merck Sharp & Dohme LLC 635
Testing effectiveness (Phase 2)Ended earlyNCT00325455
What this trial is testing

MK0859 Dose-Ranging Study (0859-003)

Who this might be right for
HypercholesterolemiaMixed Hyperlipemia
Merck Sharp & Dohme LLC 500
Large-scale testing (Phase 3)Study completedNCT00378833
What this trial is testing

Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 1,300
Large-scale testing (Phase 3)Study completedNCT00092573
What this trial is testing

Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

Who this might be right for
HypercholesterolemiaHypertriglyceridemia
Organon and Co 576
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Large-scale testing (Phase 3)Not Yet RecruitingNCT07421284
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 900
Not applicableEnded earlyNCT01228019
What this trial is testing

Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,166
Early research (Phase 1)Looking for participantsNCT07491172
What this trial is testing

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

Who this might be right for
CardiovascularMetabolic DiseaseDyslipidemias+7 more
CRISPR Therapeutics AG 90
Large-scale testing (Phase 3)Looking for participantsNCT06568471
What this trial is testing

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemiasPrimary Hypercholesterolemia+4 more
Hasten Biopharmaceutical Co., Ltd. 210
Testing effectiveness (Phase 2)Study completedNCT07278830
What this trial is testing

A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia

Who this might be right for
Hypercholesterolemia and Mixed Dyslipidemia
Shenzhen Salubris Pharmaceuticals Co., Ltd. 214
Large-scale testing (Phase 3)WithdrawnNCT02947334
What this trial is testing

Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects

Who this might be right for
Primary Hyperlipidemia or Mixed Dyslipidemia
Pfizer
Large-scale testing (Phase 3)Study completedNCT00269204
What this trial is testing

Lipid Efficacy/Tolerability Study (0524A-020)

Who this might be right for
Primary HypercholesterolaemiaMixed Hyperlipidaemia
Merck Sharp & Dohme LLC 1,620
Large-scale testing (Phase 3)Not Yet RecruitingNCT07444086
What this trial is testing

QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 510
Large-scale testing (Phase 3)Study completedNCT02189837
What this trial is testing

Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody

Who this might be right for
Primary Hyperlipidemia and Mixed Dyslipidemia
Amgen 89
Large-scale testing (Phase 3)Study completedNCT01854918
What this trial is testing

Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia

Who this might be right for
Hyperlipidemia and Mixed Dyslipidemia
Amgen 3,681
Testing effectiveness (Phase 2)Study completedNCT01105975
What this trial is testing

LY2484595 in Patients With High LDL-C or Low HDL-C

Who this might be right for
Dyslipidemia
Eli Lilly and Company 398
Early research (Phase 1)Study completedNCT01012219
What this trial is testing

Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 36
Next Page